Dennis E. Condon, President, Chief Business Officer and Director of BioForm Medical Inc is featured in an Executive Profile in the online pub. Bioform manufactures the Radiesse filler. Dennis Condon: Executive Profile & Biography - BusinessWeek:

Dennis E. Condon has been President and Chief Business Officer of BioForm Medical Inc., since June 2007. Mr. Condon has a strong background in sales, physician education, and direct consumer marketing, and a philosophy of total customer service and support. From March 2006 to June 2007, he served as Chief Executive Officer and President of Apsara Medical. Mr. Condon served as Chief Executive Officer and President of Reliant Technologies Inc. from February 2005 to November ... 2005 and also served as its Executive Vice President. Since November 2002, Mr. Condon has also served as a principal of a privately-held medical aesthetics services practice. He Co-founded and served as Chief Executive Officer and President of the Plastic Surgery Company, from June 1998 to July 2002. His proven leadership record includes 20 years of experience in the aesthetic and medical device marketplace. His broad-based experience with Mentor also includes tenure as Senior Vice President and Vice President of Sales and Marketing (Surgical Products Division) where he had both domestic and international responsibility. In addition, Mr. Condon served as Vice President of International Sales and Marketing at the Heyer-Schulte Division of American Hospital Supply Corporation. He served for 14 years at Mentor Corporation. He served at Mentor Corporation from 1991 to 1998, as Division President of Mentor's Aesthetics Subsidiary.He has been Director of BioForm Medical, Inc. since March 4, 2009.

Etc. etc.

Read it all. The report includes compensation info and industry affiliations.

The Beverly Hills Rhinoplasty Surgery Blog published a worthwhile critique of a 2007 report -- published in the Archives of Dermatology -- that claimed that the injection of crosslinked hyaluronic acid fillers, such as  Restylane and Juvederm, stimulated new collagen production. A new study looked at the injection of Radiesse and found no increase in collagen production.

Peyman Solieman, MD, and Jason Litner, MD, FRCSC, write:

We decided to review both papers to see if we could find the source of the discrepancy, and we think we may have. It seems that those who cite the original Restylane paper may not have noticed that, in the study, volunteers had an entire syringe of Restylane injected in one small area identified on the forearm. One to three separate sites were injected this way and then samples were taken that showed increased collagen production. Why is this important?

Simply put, this study does not make a lot of sense for at least 2 reasons. First, and most important, no one injects an entire syringe of Restylane into one designated area. It is generally used in the face to fill in wrinkles distributed over some distance. Since the doctors propose that mechanical stretch is the reason they think new collagen production is induced, we now can discern that it would take a whole lot of Restylane to be injected into any one area of the face to allow for collagen production. Not only would this likely be cost prohibitive, but it would also counter normal aesthetics. Second, the study used the forearm of participants to examine the effects, and we know that skin from different areas of the body respond differently to injection of these fillers.

Read it all.